mRNA Vaccines and Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Type, Application, Treatment Type, End User, and Region

Description

List of Tables

The global mRNA vaccines and therapeutics market size is expected to reach USD 253.83 billion by 2034, according to a new study by Polaris Market Research. The report "mRNA Vaccines and Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Type (Self-Amplifying mRNA-Based Vaccines and Conventional Non-Amplifying mRNA-Based Vaccines), Application, Treatment Type, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The mRNA vaccines and therapeutics market has seen a rapid evolution, particularly with the emergence of the COVID-19 outbreak. Messenger RNA (mRNA) technology emerged as an approach for COVID-19 vaccine development, offering unprecedented speed and flexibility. This innovation has created the way for rapid vaccine production during the pandemic and holds immense potential for future vaccines and therapeutics for a wide array of diseases such as influenza, cancer, and HIV.

Traditional vaccine development often requires lengthy processes to identify the most suitable antigens, grow virus samples, and produce large quantities of vaccine doses. In contrast, mRNA technology allows for rapid sequencing of a pathogen's genetic code, followed by the synthesis of mRNA that encodes the required antigen. This means that mRNA vaccines can be developed for any infectious disease as soon as its genetic sequence is known. This capability has prompted the exploration of mRNA vaccines for diseases beyond COVID-19, including influenza and Zika virus.

mRNA therapeutics are being explored for other applications, particularly in oncology. Several companies, including Moderna and BioNTech, have begun clinical trials for mRNA-based cancer vaccines, with promising early results. These vaccines may potentially be used to treat a variety of cancers, as standalone therapies or in combination with other treatments such as chemotherapy and immunotherapy.

mRNA Vaccines and Therapeutics Market Report Highlights

In terms of application, the cancer segment is expected to grow at a rapid pace during the forecast period owing to the ability of mRNA technology to revolutionize cancer treatment by enabling the development of personalized cancer vaccines and cancer immunotherapies.

Based on type, the conventional non-amplifying mRNA-based vaccines segment dominated the mRNA vaccines and therapeutics market share in 2024 owing to their proven efficacy and widespread adoption during the COVID-19 outbreak.

In the global market, North America held the largest revenue share in 2024 due to robust healthcare infrastructure, significant investments in research and development, and rapid advancements in mRNA technology.

A few of the global key market players are Pfizer Inc.; Moderna, Inc.; BioNTech SE; GlaxoSmithKline; Daiichi Sankyo; BioNTech SE; CureVac N.V.; AstraZeneca; Ethris; Sanofi; Arcturus Therapeutics; Innovac Therapeutics; Kernal Biologics; Pantherna Therapeutics; pHion Therapeutics; Recode Therapeutics; Rejuvenation Technologies; RNAimmune; Strand Therapeutics; Walvax; and Ziphius Vaccines.

Polaris Market Research has segmented the mRNA vaccines and therapeutics market report on the basis of type, application, treatment type, end user, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Self-Amplifying mRNA-Based Vaccines
Conventional Non-Amplifying mRNA-Based Vaccines

By Application Outlook (Revenue, USD Billion, 2020-2034)

Cancer
Infectious Diseases
Autoimmune Diseases
Others

By Treatment Type Outlook (Revenue, USD Billion, 2020-2034)

Monoclonal Antibody
Gene Therapy
Cell Therapy
Other

By End User Outlook (Revenue, USD Billion, 2020-2034)

Research Laboratories and Organizations
Hospitals
Clinics
Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM5328

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global mRNA Vaccines and Therapeutics Market Insights

4.1. mRNA Vaccines and Therapeutics Market - Market Snapshot
4.2. mRNA Vaccines and Therapeutics Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Growing Research and Development (R&D), Collaborations, and Strategic Partnerships
  - 4.2.1.2. Increased Regulatory Approvals for mRNA-based Products
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Strict regulatory norms
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. mRNA Vaccines and Therapeutics Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global mRNA Vaccines and Therapeutics Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
5.3. Self-amplifying mRNA-based Vaccines
- 5.3.1. Global mRNA Vaccines and Therapeutics Market, by Self-amplifying mRNA-based Vaccines, by Region, 2020-2034 (USD Billion)
5.4. Conventional Non-amplifying mRNA-based Vaccines
- 5.4.1. Global mRNA Vaccines and Therapeutics Market, by Conventional Non-amplifying mRNA-based Vaccines, by Region, 2020-2034 (USD Billion)

6. Global mRNA Vaccines and Therapeutics Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
6.3. Cancer
- 6.3.1. Global mRNA Vaccines and Therapeutics Market, by Cancer, by Region, 2020-2034 (USD Billion)
6.4. Infectious Diseases
- 6.4.1. Global mRNA Vaccines and Therapeutics Market, by Infectious Diseases, by Region, 2020-2034 (USD Billion)
6.5. Autoimmune Diseases
- 6.5.1. Global mRNA Vaccines and Therapeutics Market, by Autoimmune Diseases, by Region, 2020-2034 (USD Billion)
6.6. Others
- 6.6.1. Global mRNA Vaccines and Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global mRNA Vaccines and Therapeutics Market, by Treatment Type

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
7.3. Monoclonal Antibody
- 7.3.1. Global mRNA Vaccines and Therapeutics Market, by Monoclonal Antibody, by Region, 2020-2034 (USD Billion)
7.4. Gene Therapy
- 7.4.1. Global mRNA Vaccines and Therapeutics Market, by Gene Therapy, by Region, 2020-2034 (USD Billion)
7.5. Cell Therapy
- 7.5.1. Global mRNA Vaccines and Therapeutics Market, by Cell Therapy, by Region, 2020-2034 (USD Billion)
7.6. Others
- 7.6.1. Global mRNA Vaccines and Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global mRNA Vaccines and Therapeutics Market, by End User

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
8.3. Research Laboratories and Organizations
- 8.3.1. Global mRNA Vaccines and Therapeutics Market, by Research Laboratories and Organizations, by Region, 2020-2034 (USD Billion)
8.4. Hospitals
- 8.4.1. Global mRNA Vaccines and Therapeutics Market, by Hospitals, by Region, 2020-2034 (USD Billion)
8.5. Clinics
- 8.5.1. Global mRNA Vaccines and Therapeutics Market, by Clinics, by Region, 2020-2034 (USD Billion)
8.6. Others
- 8.6.1. Global mRNA Vaccines and Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global mRNA Vaccines and Therapeutics Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. mRNA Vaccines and Therapeutics Market Assessment, By Geography, 2020-2034 (USD Billion)
9.3. mRNA Vaccines and Therapeutics Market - North America
- 9.3.1. North America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 9.3.2. North America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 9.3.3. North America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
- 9.3.4. North America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.3.5. mRNA Vaccines and Therapeutics Market - US
  - 9.3.5.1. US: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.3.5.2. US: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.3.5.3. US: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.3.5.4. US: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.3.6. mRNA Vaccines and Therapeutics Market - Canada
  - 9.3.6.1. Canada: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.3.6.2. Canada: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.3.6.3. Canada: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.3.6.4. Canada: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
9.4. mRNA Vaccines and Therapeutics Market - Europe
- 9.4.1. Europe: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 9.4.2. Europe: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 9.4.3. Europe: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
- 9.4.4. Europe: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.4.5. mRNA Vaccines and Therapeutics Market - UK
  - 9.4.5.1. UK: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.4.5.2. UK: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.4.5.3. UK: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.4.5.4. UK: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.4.6. mRNA Vaccines and Therapeutics Market - France
  - 9.4.6.1. France: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.4.6.2. France: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.4.6.3. France: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.4.6.4. France: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.4.7. mRNA Vaccines and Therapeutics Market - Germany
  - 9.4.7.1. Germany: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.4.7.2. Germany: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.4.7.3. Germany: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.4.7.4. Germany: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.4.8. mRNA Vaccines and Therapeutics Market - Italy
  - 9.4.8.1. Italy: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.4.8.2. Italy: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.4.8.3. Italy: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.4.8.4. Italy: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.4.9. mRNA Vaccines and Therapeutics Market - Spain
  - 9.4.9.1. Spain: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.4.9.2. Spain: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.4.9.3. Spain: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.4.9.4. Spain: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.4.10. mRNA Vaccines and Therapeutics Market - Netherlands
  - 9.4.10.1. Netherlands: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.4.10.2. Netherlands: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.4.10.3. Netherlands: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.4.10.4. Netherlands: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.4.11. mRNA Vaccines and Therapeutics Market - Russia
  - 9.4.11.1. Russia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.4.11.2. Russia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.4.11.3. Russia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.4.11.4. Russia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.4.12. mRNA Vaccines and Therapeutics Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.4.12.2. Rest of Europe: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.4.12.3. Rest of Europe: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.4.12.4. Rest of Europe: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
9.5. mRNA Vaccines and Therapeutics Market - Asia Pacific
- 9.5.1. Asia Pacific: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.5.5. mRNA Vaccines and Therapeutics Market - China
  - 9.5.5.1. China: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.5.5.2. China: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.5.5.3. China: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.5.5.4. China: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.5.6. mRNA Vaccines and Therapeutics Market - India
  - 9.5.6.1. India: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.5.6.2. India: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.5.6.3. India: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.5.6.4. India: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.5.7. mRNA Vaccines and Therapeutics Market - Malaysia
  - 9.5.7.1. Malaysia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.5.7.2. Malaysia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.5.7.3. Malaysia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.5.7.4. Malaysia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.5.8. mRNA Vaccines and Therapeutics Market - Japan
  - 9.5.8.1. Japan: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.5.8.2. Japan: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.5.8.3. Japan: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.5.8.4. Japan: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.5.9. mRNA Vaccines and Therapeutics Market - Indonesia
  - 9.5.9.1. Indonesia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.5.9.2. Indonesia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.5.9.3. Indonesia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.5.9.4. Indonesia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.5.10. mRNA Vaccines and Therapeutics Market - South Korea
  - 9.5.10.1. South Korea: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.5.10.2. South Korea: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.5.10.3. South Korea: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.5.10.4. South Korea: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.5.11. mRNA Vaccines and Therapeutics Market - Australia
  - 9.5.11.1. Australia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.5.11.2. Australia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.5.11.3. Australia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.5.11.4. Australia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.5.12. mRNA Vaccines and Therapeutics Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.5.12.2. Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.5.12.3. Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.5.12.4. Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
9.6. mRNA Vaccines and Therapeutics Market - Middle East & Africa
- 9.6.1. Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.6.5. mRNA Vaccines and Therapeutics Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.6.5.2. Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.6.5.3. Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.6.5.4. Saudi Arabia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.6.6. mRNA Vaccines and Therapeutics Market - UAE
  - 9.6.6.1. UAE: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.6.6.2. UAE: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.6.6.3. UAE: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.6.6.4. UAE: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.6.7. mRNA Vaccines and Therapeutics Market - Israel
  - 9.6.7.1. Israel: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.6.7.2. Israel: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.6.7.3. Israel: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.6.7.4. Israel: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.6.8. mRNA Vaccines and Therapeutics Market - South Africa
  - 9.6.8.1. South Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.6.8.2. South Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.6.8.3. South Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.6.8.4. South Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.6.9. mRNA Vaccines and Therapeutics Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.6.9.2. Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.6.9.3. Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.6.9.4. Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
9.7. mRNA Vaccines and Therapeutics Market - Latin America
- 9.7.1. Latin America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
- 9.7.2. Latin America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
- 9.7.3. Latin America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
- 9.7.4. Latin America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.7.5. mRNA Vaccines and Therapeutics Market - Mexico
  - 9.7.5.1. Mexico: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.7.5.2. Mexico: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.7.5.3. Mexico: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.7.5.4. Mexico: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.7.6. mRNA Vaccines and Therapeutics Market - Brazil
  - 9.7.6.1. Brazil: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.7.6.2. Brazil: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.7.6.3. Brazil: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.7.6.4. Brazil: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.7.7. mRNA Vaccines and Therapeutics Market - Argentina
  - 9.7.7.1. Argentina: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.7.7.2. Argentina: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.7.7.3. Argentina: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.7.7.4. Argentina: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
- 9.7.8. mRNA Vaccines and Therapeutics Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  - 9.7.8.2. Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  - 9.7.8.3. Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  - 9.7.8.4. Rest of Latin America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Pfizer Inc.
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Moderna, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. BioNTech SE
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. GlaxoSmithKline
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Daiichi Sankyo
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. BioNTech SE
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. CureVac N.V.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. AstraZeneca
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Ethris
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Sanofi
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Arcturus Therapeutics
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Innovac Therapeutics
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. Kernal Biologics
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Pantherna Therapeutics
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
11.15. Ziphius Vaccines
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development

Product Code: PM5328

List of Tables:

Table 1 Global mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 2 Global mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 3 Global mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 4 Global mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 5 North America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 6 North America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 7 North America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 8 North America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 9 U.S.: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 10 U.S.: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 11 U.S.: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 12 U.S.: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 13 Canada: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 14 Canada: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 15 Canada: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 16 Canada: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 17 Europe: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 18 Europe: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 19 Europe: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 20 Europe: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 21 UK: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 22 UK: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 23 UK: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 24 UK: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 25 France: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 26 France: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 27 France: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 28 France: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 29 Germany: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 30 Germany: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 31 Germany: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 32 Germany: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 33 Italy: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 34 Italy: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 35 Italy: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 36 Italy: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 37 Spain: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 38 Spain: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 39 Spain: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 40 Spain: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 41 Netherlands: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 42 Netherlands: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 43 Netherlands: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 44 Netherlands: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 45 Russia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 46 Russia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 47 Russia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 48 Russia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 49 Rest of Europe: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 50 Rest of Europe: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 51 Rest of Europe: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 52 Rest of Europe: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 53 Asia Pacific: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 54 Asia Pacific: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 55 Asia Pacific: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 56 Asia Pacific: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 57 China: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 58 China: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 59 China: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 60 China: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 61 India: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 62 India: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 63 India: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 64 India: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 65 Malaysia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 66 Malaysia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 67 Malaysia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 68 Malaysia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 69 Japan: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 70 Japan: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 71 Japan: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 72 Japan: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 73 Indonesia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 74 Indonesia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 75 Indonesia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 76 Indonesia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 77 South Korea: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 78 South Korea: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 79 South Korea: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 80 South Korea: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 81 Australia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 82 Australia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 83 Australia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 84 Australia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 85 Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 86 Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 87 Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 88 Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 89 Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 90 Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 91 Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 92 Middle East & Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 93 Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 94 Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 95 Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 96 Saudi Arabia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 97 UAE: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 98 UAE: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 99 UAE: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 100 UAE: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 101 Israel: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 102 Israel: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 103 Israel: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 104 Israel: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 105 South Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 106 South Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 107 South Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 108 South Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 109 Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 110 Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 111 Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 112 Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 113 Latin America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 114 Latin America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 115 Latin America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 116 Latin America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 117 Mexico: mRNA vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 118 Mexico: mRNA vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 119 Mexico: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 120 Mexico: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 121 Brazil: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 122 Brazil: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 123 Brazil: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 124 Brazil: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 125 Argentina: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 126 Argentina: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 127 Argentina: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 128 Argentina: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 129 Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 130 Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 131 Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 132 Rest of Latin America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global mRNA Vaccines and Therapeutics Market, 2020-2034 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Price

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Type

Figure 7. Global mRNA Vaccines and Therapeutics Market, by Type, 2024 & 2034 (USD Billion)

Figure 8. Market by Application

Figure 9. Global mRNA Vaccines and Therapeutics Market, by Application, 2024 & 2034 (USD Billion)

Figure 10. Market by Treatment Type

Figure 11. Global mRNA Vaccines and Therapeutics Market, by Treatment Type, 2024 & 2034 (USD Billion)

Figure 12. Market by End User

Figure 13. Global mRNA Vaccines and Therapeutics Market, by End User, 2024 & 2034 (USD Billion)

mRNA Vaccines and Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Type, Application, Treatment Type, End User, and Region - Market Forecast, 2025-2034